Risks and benefits of adjuvant therapy for kidney cancer
Treatment of people with intermediate to high risk renal cell [...]
Treatment of people with intermediate to high risk renal cell [...]
A recent study published in Journal of Clinical Medicine this [...]
This phase Ib study reports the results of a combination [...]
Results from a phase Ib/II study looking at lenvatinib plus [...]
In a small phase 2 study presented at the virtual [...]
Immunotherapy has revolutionised treatment in many cancers, including renal cell [...]
In this phase 1b/2 study the researchers looked at a [...]
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
In this video interview, Dr Jeffrey Kirshner from the Haematology-Oncology Associates [...]
In a phase I study to look at the safety [...]